Immucell (ICCC) EBT Margin (2010 - 2026)
Immucell's (ICCC) quarterly EBT Margin came in at 37.32% in Q4 2025, down 4403.0% YoY from 0.87% in Q4 2024, and down 1418.75% on a QoQ basis from 2.46% in Q3 2025.
Immucell (ICCC) EBT Margin (2010 - 2026) Analysis & Trends
Immucell (ICCC) has 16 years of EBT Margin data on file, last reported at 37.32% in Q4 2025.
- Quarterly EBT Margin fell 4403.0% year-over-year to 37.32% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 3.72% (up 646.0% YoY) and the FY2025 annual result came in at 3.72%, up 438.0% from the prior year.
- EBT Margin fell to 37.32% in Q4 2025, from 2.46% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 17.96% in Q1 2025 to a low of 2540.78% in Q2 2024.
- A 5-year average of 145.15% and a median of 10.74% in 2021 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2024 — EBT Margin sank 250177 bps — and 2025, when it surged 254860 bps.
- Tracing ICCC's EBT Margin over 5 years: stood at 1.38% in 2021, then sank by 3182 bps to 42.61% in 2022, then surged by 59 bps to 17.41% in 2023, then jumped by 139 bps to 6.72% in 2024, then tumbled by 656 bps to 37.32% in 2025.
- The last three EBT Margin figures came in at 37.32% (Q4 2025), 2.46% (Q3 2025), and 7.82% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 86.46 Bn | 78.47 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 65.62 Bn | 60.44 Bn | 1.37 Bn | 35.71% |
| 4 | Moderna | 58.37 Bn | 53.24 Bn | 52.00 Mn | -528.97% |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 18.33% |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.43 Bn | 992.69 Mn | 13.77% |
| 7 | BioNTech SE | 28.27 Bn | 9.87 Bn | 668.28 Mn | -25.06% |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | -2.67% |
| 9 | Royalty Pharma | 27.23 Bn | 26.40 Bn | - | 12.09% |
| 10 | Immucell | 91.10 Mn | 82.24 Mn | 2.44 Mn | 26.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.17% |
| Dec 31, 2025 | -37.32% |
| Sep 30, 2025 | -2.46% |
| Jun 30, 2025 | 7.82% |
| Mar 31, 2025 | 17.96% |
| Dec 31, 2024 | 6.72% |
| Sep 30, 2024 | -11.65% |
| Jun 30, 2024 | -2,540.78% |
| Mar 31, 2024 | -6.01% |
| Sep 30, 2023 | -17.41% |
| Jun 30, 2023 | -39.01% |
| Mar 31, 2023 | -67.13% |
| Dec 31, 2022 | -42.61% |
| Sep 30, 2022 | -13.58% |
| Jun 30, 2022 | -17.69% |
| Mar 31, 2022 | 8.57% |
| Dec 31, 2021 | 1.38% |
| Sep 30, 2021 | 3.03% |
| Jun 30, 2021 | 3.11% |
| Mar 31, 2021 | -10.74% |